Late Breaking Abstract - Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival.

J. van Meerbeeck (Edegem (Antwerp), Belgium), A. Dingemans (Rotterdam, Netherlands), L. Horn (Nashville, United States of America), V. Torri (Milano, Italy), J. Whisenant (Nashville, United States of America), H. Wakelee (Stanford, United States of America), S. Peters (Lausanne, Switzerland), M. Garassino (Milan, Italy), J. Cadranel (Paris, France), J. Chorostowska (Warsaw, Poland)

Source: Virtual Congress 2020 – COVID-19 clinical studies
Session: COVID-19 clinical studies
Session type: E-poster session
Number: 3584

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. van Meerbeeck (Edegem (Antwerp), Belgium), A. Dingemans (Rotterdam, Netherlands), L. Horn (Nashville, United States of America), V. Torri (Milano, Italy), J. Whisenant (Nashville, United States of America), H. Wakelee (Stanford, United States of America), S. Peters (Lausanne, Switzerland), M. Garassino (Milan, Italy), J. Cadranel (Paris, France), J. Chorostowska (Warsaw, Poland). Late Breaking Abstract - Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival.. 3584

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival
Source: Virtual Congress 2020 – Thoracic oncology
Year: 2020


Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Late Breaking Abstract - NORdic Database for aSThmA Research (NORDSTAR): Swedish and Finnish patients
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018


Comparison of British and American Thoracic Societies’ reintroduction guidelines for anti-tuberculous therapy induced liver injury
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey.
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019



Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015

Anticancer chemotherapy combined with anti-tuberculosis treatment: A systematic review
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


Primary melanoma of bronchus: Report of 4 cases
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Lung cancer, has it changed in the last ten years?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015


Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Radiation pneumonitis; early diagnosis and associated factors
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Interventional management and outcome of lung cancer and cardiac disease. Meta-analytic review
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015